Insider Buying: Dr. Martens (LON:DOCS) Insider Purchases £149.60 in Stock

Dr. Martens plc (LON:DOCS) insider Ije Nwokori acquired 220 shares of the company’s stock in a transaction on Monday, October 12th. The stock was purchased at an average cost of GBX 68 per share, for a total transaction of £149.60.

Ije Nwokori also recently made the following trade(s):

• On Friday, September 11th, Ije Nwokori acquired 232 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 65 per share, for a total transaction of £150.80.
• On Tuesday, August 11th, Ije Nwokori acquired 179 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 84 per share, for a total transaction of £150.36.

Dr. Martens Price Performance

Dr. Martens stock opened at GBX 68.30 on Wednesday. The stock has a market cap of £653.75 million, a P/E ratio of 28.46, a price-to-earnings-growth ratio of 6.40 and a beta of 0.26. The company has a fifty day simple moving average of GBX 73.86 and a 200-day simple moving average of GBX 70.98. Dr. Martens plc has a 12-month low of GBX 59.15 and a 12-month high of GBX 97.05. The company has a current ratio of 2.61, a quick ratio of 1.13 and a debt-to-equity ratio of 108.85.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank restated a “buy” rating and issued a GBX 110 price target on shares of Dr. Martens in a research note on Friday, October 9th. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of GBX 105.

About Dr. Martens

Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot – named after the date it was produced – rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, “Docs” or “DM’s” were later adopted by musicians and subcultural pioneers who took them from the street to the global stage.

Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people.